Strategic Partnerships MIRA’s FDA De Novo clearance and ongoing industry collaborations (examples with Advanced Endoscopy Devices and Cultivate MD investments) indicate strong appetite for ecosystem partnerships. Target companies and distributors in medical robotics, endoscopy, and surgical platforms for co-development, integration, and bundled RAS solutions.

Market Expansion Current focus on miniaturized robotic assisted surgery positions Virtual Incision to expand into hospitals aiming to upgrade OR capabilities with cost-effective, accessible RAS. Identify mid to large academic medical centers and regional health systems seeking less invasive robotic options and shorter learning curves.

Clinical Adoption With a growing patent portfolio and recognition such as the Governor’s Bioscience Award, emphasize clinical adoption momentum. Pitch to surgeons and department leaders highlighting outcomes, training programs, and streamlined integration into existing surgical workflows.

Investment Readiness Significant funding and strategic investments suggest a receptive environment for co-marketing, co-development, and customer-funded pilot programs. Propose joint ventures, trial programs, or financing partnerships to accelerate deployment in target hospitals.

Technology Enablement Strong tech stack and embedded Linux based platform indicate compatibility with customizable software ecosystems. Approach software and device integrators, EMR vendors, and hospital IT to enable seamless data flows, interoperability, and perioperative analytics around MIRA deployments.